Clinical Trials: Acute Myelogenous Leukemia (AML)

California

Duarte; City of Hope
SWOG 9007: Cytogenetic Studies In Leukemia Patients

Duarte; City of Hope
CIBMRT 05-DCB: A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation (UCBT) in Adults with Hematologic Malignancy

Duarte; City of Hope
PHII-86 NCI #7925: A Phase 2 Study of AZD6244 in Relapsed or Refractory AML

Duarte; City of Hope
Protocol PR1-104 - Randomized, Blinded, Multicenter Study of Proteinase 3 PR1 Peptide Mixed with Montanide ISA-51 VG Adjuvant and Administered with GM-CSF in Elderly Patients with AML in First Complete Remission or Adults in Second Complete Remission: A Pivotal Study

Indiana

Beech Grove; American Health Network of Indiana LLC, Oncology Division
Phase II; First Line Treatment

New York

Bronx; Biomedical Research Alliance of New York
Leukemia - Acute Myelogenous (AML)

New York; Biomedical Research Alliance of New York
A clinical study to test an experimental drug in patients with acute myelogenous leukemia (AML)

Texas

Houston; Research Center
A Phase I/II, Open-Label, Multi-centre 2-part study to assess the Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1152 in Patients WIth Relapsed Acute Myeloid Leukaemia.

Virginia

Charlottesville; University of Virginia
Children, Adolescents, and Young Adults with Acute Myeloid Leukemia (AML) Sought for Research Study